Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 205,823,314 papers from all fields of science
Search
Sign In
Create Free Account
FCE 24517
Known as:
FCE-24517
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
tallimustine
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
FCE 24517-resistant MCF-7 human breast cancer cell line: selection and characterization.
C. Salvatore
,
M. Bigioni
,
E. Iafrate
,
M. Cianfriglia
,
S. Manzini
Anti-cancer drugs
1999
Corpus ID: 22010890
We have developed a stable line of the human breast carcinoma cell line MCF-7 by in vitro continuous exposure to increasing…
Expand
1998
1998
A phase I and pharmacokinetic study of tallimustine [PNU 152241 (FCE 24517)] in patients with advanced cancer.
G. Weiss
,
I. Poggesi
,
+8 authors
P. O'dwyer
Clinical cancer research : an official journal of…
1998
Corpus ID: 27580338
Tallimustine [PNU 152241 (FCE 24517)] is a synthetic derivative of the DNA minor groove binder distamycin A, in which the NH2…
Expand
1996
1996
Backbone and benzoyl mustard carrying moiety modifies DNA interactions of distamycin analogues.
A. Ciucci
,
S. Manzini
,
P. Lombardi
,
F. Arcamone
Nucleic acids research
1996
Corpus ID: 11719260
Alkylating distamycin derivative FCE-24517 (l) is the prototype of a novel class of alkylating agents. In the present study we…
Expand
1994
1994
3T3 NIH murine fibroblasts and B78 murine melanoma cells expressing the Escherichia coli N3-methyladenine-DNA glycosylase I do not become resistant to alkylating agents.
L. Imperatori
,
G. Damia
,
+4 authors
M. D’Incalci
Carcinogenesis
1994
Corpus ID: 2187962
The role of alkylation of the N3 position of adenine in the cytotoxicity of alkylating agents in mammalian cells is still…
Expand
1993
1993
Characterisation of a LoVo subline resistant to a benzoyl mustard derivative of distamycin A (FCE 24517).
L. Capolongo
,
G. Melegaro
,
M. Broggini
,
N. Mongelli
,
M. Grandi
British Journal of Cancer
1993
Corpus ID: 9239640
Human colon adenocarcinoma cells (LoVo) resistant to the new antitumor agent FCE 24517 [benzoyl-mustard derivative of distamycin…
Expand
1993
1993
Intracellular glutathione heterogeneity in L1210 murine leukemia sublines made resistant to dna‐interacting anti‐neoplastic agents
G. Tagliabue
,
P. Ubezio
,
+4 authors
C. Geroni
International journal of cancer
1993
Corpus ID: 6357171
Intracellular glutathione (GSH) content was measured by flow cytometry using monochlorobimane (mBCI) and by the enzymatic assay…
Expand
1993
1993
The effects of a benzoic acid mustard derivative of distamycin A (FCE 24517) and related minor groove-binding distamycin analogues on the activity of major groove-binding alkylating agents.
H. Coley
,
N. Mongelli
,
M. D’Incalci
Biochemical pharmacology
1993
Corpus ID: 10859778
1992
1992
The unique interaction with immunity of FCE 24517, an antitumor drug with a novel mode of action.
F. Riganti
,
M. Sironi
,
+4 authors
A. Vecchi
International journal of immunopharmacology
1992
Corpus ID: 31482012
Highly Cited
1991
Highly Cited
1991
Selective DNA interaction of the novel distamycin derivative FCE 24517.
M. Broggini
,
E. Erba
,
+4 authors
M. D’Incalci
Cancer research
1991
Corpus ID: 31996548
N-Deformyl-N-(4-N-N,N-bis(2-chloroethylamino)benzoyl)distamy cin A (FCE 24517) is a novel cytotoxic and antitumor agent shortly…
Expand
Highly Cited
1991
Highly Cited
1991
Biological profile of FCE 24517, a novel benzoyl mustard analogue of distamycin A.
G. Pezzoni
,
M. Grandi
,
+7 authors
N. Mongelli
British Journal of Cancer
1991
Corpus ID: 52863974
FCE 24157 (chemically (beta-[1-methyl-4-(1-methyl-4--[1-methyl-4-(4-N,N- bis(2-chloroethyl) amino-benzene-1-carboxy-amido…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE